Status:
COMPLETED
PK of Depo SubQ Injected in the Upper Arm
Lead Sponsor:
FHI 360
Collaborating Sponsors:
Eastern Virginia Medical School
Conditions:
Contraception
Eligibility:
FEMALE
18-40 years
Phase:
NA
Brief Summary
A single-arm trial to demonstrate that Depo-SubQ Provera injected in the upper arm is adequate for effective contraception
Detailed Description
A single-arm trial to demonstrate that the blood levels of medroxyprogesterone acetate are adequate for effective contraception when Depo-SubQ Provera 104 is injected in the upper arm
Eligibility Criteria
Inclusion
- Age 18-40
- negative pregnancy test on day of injection
- not wishing to become pregnant in the next 12 months
- at negligible risk of pregnancy (e.g. sterilized, in exclusively same-gender partnership, in a monogamous relationship with vasectomized partner, abstinent, using non-hormonal IUD)
- body mass index of 18-30
Exclusion
- \-
Key Trial Info
Start Date :
May 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT01143207
Start Date
May 1 2010
End Date
October 1 2012
Last Update
August 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinical Research Center, Dept. of Obstetrics & Gynegology, Eastern Virginia Medical School
Norfolk, Virginia, United States, 23507